"Centro gastroenterológico especializado en enfermedades digestivas - Guayaquil, Ecuador. Servicios: Endoscopía, Colonoscopía, Ecoendoscopía, Manometría, Ph- Metría, Endomicroscopía, Cromoendoscopía, Cápsula Endoscópica, Fibroscan, Gastrostomía, Balón Gástrico, Coledocoscopía (SPYGLASS), Test de Aliento, POEM, Colangiopancreatografía Retrógrada Endoscópica (CPRE). Tratamientos: Esófago de Barret, Motilidad Esofágica, Acalasia, Estenosis esofágica, Reflujo Gastroesofágico, Esofagitis, Cáncer, colitis, Úlceras, Adenomas, Enfermedad Celiaca, Inflamación intestinal, Tumores, Pólipos, Enfermedad de Crohn, Linfoma, Gastritis, Metaplasia, Helicobacter pylori, Diverticulos, Hepatitis."

During the past decade, Instituto Ecuatoriano de Enfermedades Digestivas conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Ecuatoriano de Enfermedades Digestivas" #1 collaborator was "EndoscopyNet, Quito, Ecuador" with 1 trials as a collaborator and "mdconsgroup, Guayaquil, Ecuador" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Ecuatoriano de Enfermedades Digestivas" are "Atrophic Gastritis" (2 trials), "Acute Cholecystitis" (1 trials), "Bile Duct Lesions" (1 trials), "Cirrhosis" (1 trials) and "Colonic Diseases" (1 trials). Many other conditions were trialed in "Instituto Ecuatoriano de Enfermedades Digestivas" in a lesser frequency.

Most popular intervention types in "Instituto Ecuatoriano de Enfermedades Digestivas" are "Procedure" (6 trials), "Device" (4 trials), "Diagnostic Test" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CE-EUS" (1 trials), "Cellvizio Viewer software" (1 trials), "Coils + Cyanoacrylate Group + beta-blocker" (1 trials), "DFI-EUS" (1 trials) and "Digital chromoendoscopy and magnification" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Ecuatoriano de Enfermedades Digestivas" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Ecuatoriano de Enfermedades Digestivas". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Instituto Ecuatoriano de Enfermedades Digestivas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Ecuatoriano de Enfermedades Digestivas, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".